IIVS teams up with labs to validate a non-animal test for regulatory submissions
IIVS is collaborating with global laboratories to validate an improved skin sensitization reactivity method to meet toxicology and regulatory requirements.
IIVS is collaborating with global laboratories to validate an improved skin sensitization reactivity method to meet toxicology and regulatory requirements.
Pfizer announced the voluntary recall of a batch of Advil after overdose fears arose due to an error on the label.
Boehringer Ingelheim has begun construction of a new production facility for drugs in tablet form, with an expected completion date of 2020.
Bluebird bio and Gritstone Oncology have collaborated to research, develop and commercialize cancer treatments using cell therapy with an AI platform.
Deloitte’s acquisition of QSpace expands its IT quality and compliance solutions offering for life sciences firms, including contract research and manufacturing organizations.
Science Exchange has partnered with Taconic Biosciences, a supplier of genetically engineered rodent models to offer access to Taconic’s portfolio including the company’s Easi-CRISPR technology.
Glaukos Pharmaceutical, an ophthalmic medical technology and pharmaceutical company, and D. Western Therapeutics Institute (DWTI), a Japanese biotechnology company, have announced an agreement.